申请人:Merck & Co., Inc.
公开号:US05780480A1
公开(公告)日:1998-07-14
Fibrinogen receptor antagonists of the general formula: X-A-Y-Z-B I and which includes, for example, the compounds of formula ##STR1## are useful for inhibiting the binding of fibrinogen to blood platelets, inhibiting the aggregation of blood platelets, treating thrombus formation or embolus formation, and preventing thrombus or embolus formation.
一般公式为:X-A-Y-Z-B的纤维蛋白原受体拮抗剂,例如包括公式##STR1##的化合物,可用于抑制纤维蛋白原与血小板的结合,抑制血小板聚集,治疗血栓形成或栓塞形成,并预防血栓或栓塞形成。